Results 31 to 40 of about 18,294 (302)

Industry Payments to Physicians and Prescribing of Brand-name Drugs [PDF]

JAMA Internal Medicine, 2016
Under the Open Payments program (the Physician Payment SunshineAct,which ispartof theAffordableCareAct), theCenters forMedicareM clearly theybelieve that billions of dollars of investments will have good returns. In this issue of JAMA Internal Medicine, DeJong and colleagues,1 using 2013 data from the Open Payments programandprescribingdata for ...
openaire   +2 more sources

Evaluation of the quality of prescription orders in a tertiary health-care facility in Southeastern Nigeria

CHRISMED Journal of Health and Research, 2018
Background: Prescription orders serve as a source of communication linking the physician, patient, and pharmacist. However, inappropriate prescriptions may result in medication errors, thus may worsen clinical outcome and economic burden of the patient ...
Nneka Uchenna Igboeli, Chibueze Anosike, Onyinye Blessing Ukoha-Kalu, Ebere Emilia Ayogu   +3 more
doaj   +1 more source

Difference in rural and urban Medicare prescription pattern for Parkinson’s disease in Hawai‘i

Clinical Parkinsonism & Related Disorders, 2022
Background: Medical management of Parkinson’s Disease (PD) is becoming complex. Increasing evidence suggests that patients have better outcomes when they are managed by neurologists. However, access to neurologists can be limited in rural areas. Analysis
Michiko K. Bruno, Gina Watanabe, Fay Gao, Todd Seto, Kazuma Nakagawa, Connie Trinacty, Stacy Brown, Deborah A. Taira   +7 more
doaj   +1 more source

Exploring the evidence base for national and regional policy interventions to combat resistance [PDF]

, 2015
The effectiveness of existing policies to control antimicrobial resistance is not yet fully understood. A strengthened evidence base is needed to inform effective policy interventions across countries with different income levels and the human health and
Aarestrup, Aarestrup, Ahuja, Aidara-Kane, Alimuddin Zumla, Allegranzi, Allegranzi, Amábile-Cuevas, Anthony D So, Anthony Kessel, Baertlein, Belongia, Belongia, Bushnell, Catley, Catley, Cheng, Coenen, Crowther-Gibson, Dagan, Datema, Davey, David L Heymann, De Boeck, Earnshaw, Emmeline J Buckley, Fazal K Dar, Finkelstein, Fätkenheuer, Gerber, Govin Permanand, Grave, Grave, Grazia Caleo, Grundmann, Hammerum, Hanne Bak Pedersen, Harbarth, Haydar Giha, Hennessy, Henry Lishi Li, Heuer, Holloway, Huttner, Huttner, Jack, Jasper Littmann, John-Arne Røttingen, Jørgen Schlundt, Kariuki, Katakweba, Khalid M Bindayna, Khan, Komolafe, Kümmerer, Little, Luoto, Mandal, Mark Rweyemamu, Marti, McNulty, Mishal Khan, Mitj, Mohammed Shahid, Moyane, Mshana, Nisi, Ogan, Okeke, Okeke, Okeke, Osman A Dar, Parry, Pittet, Pletz, Radley, Ranji, Richard Kock, Rumina Hasan, Silverman, Simonsen, Song, Speksnijder, Spurling, Stephan Harbarth, Vanden Eng, Vernet, Versporten, Versporten, Viberg, Vlieghe, Walt, Xiao, Zingg   +93 more
core   +2 more sources

The magnitude of prescribing medicines by brand names in a tertiary hospital, Mwanza, Tanzania

The Journal of Medicine Access, 2022
Background: Globally, one of the most common causes of irrational use of medicines is brand-name prescribing. The consequence of prescribing medicines using brand names is an economic burden on patients and society. Thus, this study aimed to investigate the magnitude of prescribing medicines by brand names in a tertiary hospital in Mwanza, Tanzania ...
Stanley Mwita, Brigitte Mchau, Winfrida Minja, Deogratias Katabalo, Kayo Hamasaki, Karol Marwa   +5 more
openaire   +2 more sources

What are the ‘active ingredients’ of interventions targeting the public's engagement with antimicrobial resistance and how might they work? [PDF]

, 2018
Objectives. Changing public awareness of antimicrobial resistance (AMR) represents a global public health priority. A systematic review of interventions that targeted public AMR awareness and associated behaviour was previously conducted.
Davis, Mark, Flowers, Paul, Gozdzielewska, Lucyna, Langdridge, Darren, MacDonald, Jennifer, McParland, Joanna L., Price, Lesley, Smith, Fraser, Williams, Lynn, Young, Mairi   +9 more
core   +5 more sources

Dietary Protein Intake and Peritoneal Protein Losses in Peritoneal Dialysis Patients

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) patients lose protein in their waste dialysate, potentially increasing their risk for malnutrition. We wished to determine whether there was any association between losses and dietary protein intake (DPI). Methods DPI was assessed from 24‐h dietary recall using Nutrics software.
Haalah Shaaker, Andrew Davenport
wiley   +1 more source

Exploring the baseline knowledge and experience of healthcare professionals in the United Kingdom on Novel Psychoactive Substances [PDF]

, 2020
Submitted 28 january 2020. Reviwers' comments received 11 February 2020. Accepted 26 February 2020. Published 2 March 2020.Objective: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals
Bancroft, Angus, Corkery, John Martin, Felice, Anna Marie, Gittins, Rosalind, Guirguis, Amira, Hawksworth, Gill, Ramos, Camille, Schifano, Fabrizio, Smeeton, Nigel, Zaman, Hadar   +9 more
core   +3 more sources

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

FEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data

BMC Health Services Research, 2018
Background While many new medications may offer advantages over existing drugs, some newer drugs are reformulations of existing products that provide little innovation or incremental benefit while driving up drug costs.
Manvi Sharma, Aisha Vadhariya, Michael L. Johnson, Zachary A. Marcum, Holly M. Holmes   +4 more
doaj   +1 more source